Robert DiGregorio, PharmD, FNAP, BCACP
Senior Director, Pharmacotherapy Services, Associate Dean for Clinical Affairs and Professor, LIU-Pharmacy, Arnold & Marie Schwartz College of Pharmacy
Thank you for your interest in our residency training program. I applaud your motivation to complete post-graduate training and I am thrilled that you have considered our program as the next step in your education and training.
As a full-time academician for more than 27 years, I take pharmacy education seriously. I have built a team of residency faculty that share my passion for pharmacy practice and are eager to impart their knowledge and experience to you. I believe that we are able to offer you one of the most dynamic, challenging and rewarding programs in the country. Your PGY-1 residency year starts in mid-June with an orientation program. During this orientation, you will undergo training in basic and advanced cardiac life support, pediatric life support, conscious sedation and other areas, alongside the incoming physician house staff. You will also begin orientation to the on-call program with various “boot camps” covering antimicrobial stewardship, pharmacokinetics and various emergency medicine topics, while shadowing the current residents while they are on-call. The remaining 11 and a half months are divided into five-week-long direct patient care rotations. These rotations are split between required and elective rotations. The PGY-2 programs in Ambulatory Care, Emergency Medicine and Infectious Diseases begin in July and have a condensed orientation, specific to the program.
Our motto, “The Remedy is Experience,” reflects the overall mission of our program: afford residents the opportunity to gain experiences and knowledge in a pharmacotherapy model that functions as a think tank and proving ground for programs and services. This model promotes the concept of practicing at the “top of your license” within the hospital. Upon your completion of the program, it is anticipated that PGY-1s will be prepared for the progression into a PGY-2 program of your choice, and PGY-2s into board-eligible pharmacotherapy specialists and academicians. Ultimately, most of our alumni become board-certified and move into pharmacotherapy specialist, academic faculty positions or positions within the pharmaceutical industry. When engaging with other institutions you will take pharmacy practice to a higher level, perhaps implementing the services that you were exposed to during the residency program at TBHC. The integration of each resident into the pharmacotherapeutic services at the hospital provides a level of experience that is often not found in residency training programs.
Additionally, with five PGY-1 residents and six PGY-2 residents, there is ample opportunity to share ideas, triumphant highs and occasional lows with a supportive group. An esprit de corps is very apparent among our residents. I urge you to spend some time talking with them as part of your interview process.
Please review the materials throughout these pages, take time to meet with us and ask questions. We truly try to find candidates that will fit well with our program’s “personality.” Without the slightest hesitation, I can assure you that if you are a good fit for our program, you will grow more in one year than you could possibly imagine and you will enjoy the ride at the same time! Good luck in your quest and thanks for considering us.
Robert DiGregorio, PharmD, FNAP, BCACP
Senior Director, Pharmacotherapy Services
Associate Dean for Clinical Affairs and Professor, LIU-Pharmacy, Arnold & Marie Schwartz College of Pharmacy
TBHC is the FIRST and ONLY hospital in New York State to have their entire pharmacotherapy staff credentialed to provide CDTM services by the NYS State Education Department/Board of Pharmacy.